生物标志物在低剂量致癌物暴露危险度评价中的作用

[1] Biological effect markers forexposure to carcinogenic compound and their relevance for riskassessment. Joost H M,Robert A B,Len R. Critical Reviews in Toxicology . 1 998

[2] Monitoring theexposure of rats to benzo[a] pyrene by the determination ofmutagenic activity in excreta,chromosome aberrations and sisterchromatid exchanges in peripheral blood cells,and DNA adductsin peripheral blood lymphocytes and liver. Willems MI,Roggeband R,Baan RA,et al. Mutagenesis . 1 991

[3] Cancer risk in humanspredicted by increased levels of chromosomal aberrations inlymphocytes:Nordic strdy group on the health risk ofchromosome damage. Hagmar L,Brogger A,Hansteen IL,et al. Cancer Research . 1 994

[4] Monitoring theexposure of rats to 2 - acetylaminofluoreneby the estimation ofmutagenic activity in excreta,sister chromatid exchanges inperipheral blood cells and DNA adducts on peripheral bloodcells,liver and spleen. Willems MI,de Raat WK,Baan RA,et al. Mutation Research . 1 987

[5] Biological and chemicalmonitoring of occupational exposure to ethylene oxide. Tates AD,Grummt T,Tonqvest M,etal. Mutation Research . 1 991

[6] Molecular dosimetry of ethylene oxide:formation and persistence of N - (2 -Hydroxyethyl ) valine in hemoglobin following repeatedexposures of rats and mice. Waller VE,Mac Neela JP,Swenberg JA,etal. Cancer Research . 1 992

[7] Mortality on relation tosmoking:40 year’s observations on male Britishdoctors. Doll R,Peto R,Wheatley K,et al. British Medical Journal . 1 994

[8] Benzidine- DNA adducts levelsin human peripheral white blood cells significantly correlatewith levels in exfoliated urothelial cells. Zhou Q,Talasla G,Rothman N. Mutation Research . 1 997

[9] Urinary aflatoxin biomarkersand risk of hepatocellular carcinoma. Ross RK,Yuan JM,Yu MC,et al. The Lancet . 1 992

[10] Tumor markers inserum,polyamines and modified nucleosides in urine,andcytogenetic aberrations in lymphocytes of workers exposed topolycyclic aromatic hydrocarbons. Buchet JP,Ferreira JM,Burrion JB,et al. American Journal of Industrial Medicine . 1 995

[1] Biological effect markers forexposure to carcinogenic compound and their relevance for riskassessment. Joost H M,Robert A B,Len R. Critical Reviews in Toxicology . 1 998

[2] Monitoring theexposure of rats to benzo[a] pyrene by the determination ofmutagenic activity in excreta,chromosome aberrations and sisterchromatid exchanges in peripheral blood cells,and DNA adductsin peripheral blood lymphocytes and liver. Willems MI,Roggeband R,Baan RA,et al. Mutagenesis . 1 991

[3] Cancer risk in humanspredicted by increased levels of chromosomal aberrations inlymphocytes:Nordic strdy group on the health risk ofchromosome damage. Hagmar L,Brogger A,Hansteen IL,et al. Cancer Research . 1 994

[4] Monitoring theexposure of rats to 2 - acetylaminofluoreneby the estimation ofmutagenic activity in excreta,sister chromatid exchanges inperipheral blood cells and DNA adducts on peripheral bloodcells,liver and spleen. Willems MI,de Raat WK,Baan RA,et al. Mutation Research . 1 987

[5] Biological and chemicalmonitoring of occupational exposure to ethylene oxide. Tates AD,Grummt T,Tonqvest M,etal. Mutation Research . 1 991

[6] Molecular dosimetry of ethylene oxide:formation and persistence of N - (2 -Hydroxyethyl ) valine in hemoglobin following repeatedexposures of rats and mice. Waller VE,Mac Neela JP,Swenberg JA,etal. Cancer Research . 1 992

[7] Mortality on relation tosmoking:40 year’s observations on male Britishdoctors. Doll R,Peto R,Wheatley K,et al. British Medical Journal . 1 994

[8] Benzidine- DNA adducts levelsin human peripheral white blood cells significantly correlatewith levels in exfoliated urothelial cells. Zhou Q,Talasla G,Rothman N. Mutation Research . 1 997

[9] Urinary aflatoxin biomarkersand risk of hepatocellular carcinoma. Ross RK,Yuan JM,Yu MC,et al. The Lancet . 1 992

[10] Tumor markers inserum,polyamines and modified nucleosides in urine,andcytogenetic aberrations in lymphocytes of workers exposed topolycyclic aromatic hydrocarbons. Buchet JP,Ferreira JM,Burrion JB,et al. American Journal of Industrial Medicine . 1 995